TY - JOUR
T1 - Dysglycemia and abnormal adiposity drivers of cardiometabolic-based chronic disease in the czech population
T2 - Biological, behavioral, and cultural/social determinants of health
AU - Pavlovska, Iuliia
AU - Polcrova, Anna
AU - Mechanick, Jeffrey I.
AU - Brož, Jan
AU - Infante-Garcia, Maria M.
AU - Nieto-Martínez, Ramfis
AU - Maranhao Neto, Geraldo A.
AU - Kunzova, Sarka
AU - Skladana, Maria
AU - Novotny, Jan S.
AU - Pikhart, Hynek
AU - Urbanová, Jana
AU - Stokin, Gorazd B.
AU - Medina-Inojosa, Jose R.
AU - Vysoky, Robert
AU - González-Rivas, Juan P.
N1 - Funding Information:
The Kardiovize Brno 2030 study was supported by the European Regional Development Fund—Project FNUSA-ICRC (no. CZ.1.05/1.1.00/02.0123), by project no. LQ1605 from the National Program of Sustainability II (MEYS CR), by project ENOCH (no. CZ.02.1.01/0.0/0.0/16_019/0000868), and by a grant from the Ministry of Health of the Czech Republic (NT13434-4/2012).Acknowledgments: The authors are grateful to the team members.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/7
Y1 - 2021/7
N2 - In contrast to the decreasing burden related to cardiovascular disease (CVD), the burden related to dysglycemia and adiposity complications is increasing in Czechia, and local drivers must be identified. A comprehensive literature review was performed to evaluate biological, behavioral, and environmental drivers of dysglycemia and abnormal adiposity in Czechia. Additionally, the structure of the Czech healthcare system was described. The prevalence of obesity in men and diabetes in both sexes has been increasing over the past 30 years. Possible reasons include the Eastern European eating pattern, high prevalence of physical inactivity and health illiteracy, education, and income-related health inequalities. Despite the advanced healthcare system based on the compulsory insurance model with free-for-service healthcare and a wide range of health-promoting initiatives, more effective strategies to tackle the adiposity/dysglycemia are needed. In conclusion, the disease burden related to dysglycemia and adiposity in Czechia remains high but is not translated into greater CVD. This discordant relationship likely depends more on other factors, such as improvements in dyslipidemia and hypertension control. A reconceptualization of abnormal adiposity and dysg-lycemia into a more actionable cardiometabolic-based chronic disease model is needed to improve the approach to these conditions. This review can serve as a platform to investigate causal mechanisms and secure effective management of cardiometabolic-based chronic disease.
AB - In contrast to the decreasing burden related to cardiovascular disease (CVD), the burden related to dysglycemia and adiposity complications is increasing in Czechia, and local drivers must be identified. A comprehensive literature review was performed to evaluate biological, behavioral, and environmental drivers of dysglycemia and abnormal adiposity in Czechia. Additionally, the structure of the Czech healthcare system was described. The prevalence of obesity in men and diabetes in both sexes has been increasing over the past 30 years. Possible reasons include the Eastern European eating pattern, high prevalence of physical inactivity and health illiteracy, education, and income-related health inequalities. Despite the advanced healthcare system based on the compulsory insurance model with free-for-service healthcare and a wide range of health-promoting initiatives, more effective strategies to tackle the adiposity/dysglycemia are needed. In conclusion, the disease burden related to dysglycemia and adiposity in Czechia remains high but is not translated into greater CVD. This discordant relationship likely depends more on other factors, such as improvements in dyslipidemia and hypertension control. A reconceptualization of abnormal adiposity and dysg-lycemia into a more actionable cardiometabolic-based chronic disease model is needed to improve the approach to these conditions. This review can serve as a platform to investigate causal mechanisms and secure effective management of cardiometabolic-based chronic disease.
KW - Adiposity
KW - Cardiometabolic risk
KW - Cardiovascular disease
KW - Chronic disease
KW - Dysglycemia
KW - Insulin resistance
KW - Nutrition
KW - Obesity
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85109196091&partnerID=8YFLogxK
U2 - 10.3390/nu13072338
DO - 10.3390/nu13072338
M3 - Review article
C2 - 34371848
AN - SCOPUS:85109196091
SN - 2072-6643
VL - 13
JO - Nutrients
JF - Nutrients
IS - 7
M1 - 2338
ER -